Výsledky vyhledávání - "Keith Luckett"

Expanding the Donor Pool: First Use of Hepatitis B Virus Nat Positive Solid Organ Allografts Into Seronegative Recipients

Autor: Nadeem Anwar, Kevin M. Turner, Tiffany C. Lee, Tiffany E. Kaiser, Michael R. Schoech, Khurram Bari, Ralph C. Quillin, Aaron M. Delman, Kamran Safdar, Amit Govil, Shimul A. Shah, Keith Luckett, Madison C. Cuffy, Latifa S. Silski

Publikováno v: Annals of surgery. 274(4)

Objectives The aim of this study was to assess the 1-year safety and effectiveness of HBV Nucleic Acid Test positive (HBV NAT+) allografts in seronegative kidney transplant (KT) and liver transplant (LT) recipients. Summary background data Despite an

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::55dcfdf4900803eaa32f6ae797ec4d7f
https://pubmed.ncbi.nlm.nih.gov/34506310

Zobrazit plný text záznamu

Keeping the lights on: Telehealth, testing, and 6-month outcomes for orthotopic liver transplantation during the COVID-19 pandemic

Autor: Keith Luckett, Courtney R. Jones, Latifa S. Silski, Dennis M. Vaysburg, Corey King, Ralph C. Quillin, Shimul A. Shah, Aaron M. Delman, Kevin M. Turner, Kamran Safdar

Publikováno v: Surgery

Background The coronavirus disease 2019 (COVID-19) pandemic has seen transplant volume decrease nationwide, resulting in a 2.2-fold increase in waitlist mortality. In particular, solid organ transplant patients are subjected to increased morbidity an

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4e5e040644529ede7483e8de47ea8a31

Zobrazit plný text záznamu

Hepatitis C transmission from seropositive, nonviremic donors to non–hepatitis C liver transplant recipients

Autor: Stephen D. Zucker, Keith Luckett, Tayyab S. Diwan, Michael R. Schoech, Senu Apewokin, Tiffany E. Kaiser, Madison C. Cuffy, Khurram Bari, Nadeem Anwar, Kamran Safdar, Shimul A. Shah, Kenneth E. Sherman, Flavio Paterno, Jason T. Blackard

Publikováno v: Hepatology. 67:1673-1682

Breakthroughs in Hepatitis C virus (HCV) treatment and rising rates of intravenous drug use have led to an increase in the number of organ donors that are HCV antibody positive but serum nucleic acid test (NAT) negative. The risk of HCV transmission

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5ec345451b0049ad87e5598e720216d8
https://doi.org/10.1002/hep.29704

Zobrazit plný text záznamu

Use, Safety, and Effectiveness of Viremic Hepatitis B Virus Donor Livers: A Potential Opportunity to Expand the Donor Pool

Autor: Leah K. Winer, Kamran Safdar, Koffi Wima, Tiffany C. Lee, Nadeem Anwar, Tiffany E. Kaiser, Khurram Bari, R. Cutler Quillin, Keith Luckett, Shimul A. Shah, Mackenzie C. Morris, Al-Faraaz Kassam

Publikováno v: Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society. 25(10)

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c20d851b918d3b9ad240e5e5b38c86fb
https://pubmed.ncbi.nlm.nih.gov/31273919

Zobrazit plný text záznamu

Use of HCV Ab+/NAT- donors in HCV naïve renal transplant recipients to expand the kidney donor pool

Autor: Shimul A. Shah, Tayyab S. Diwan, Ann Dao, A. H. Rike, John Cafardi, Amit Govil, Madison C. Cuffy, E. S. Woodle, Kenneth E. Sherman, Keith Luckett, Rita R. Alloway, Ashley Loethen, Michael Cardi, Tiffany E. Kaiser

Publikováno v: Clinical transplantation. 33(7)

Hepatitis C (HCV) disease transmission from the use of HCV antibody-positive and HCV nucleic acid test-negative (HCV Ab+/NAT-) kidneys have been anecdotally reported to be absent. We prospectively analyzed kidney transplant (KT) outcomes from HCV Ab+

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::511bda60711fae7fe922cdf9389e921d
https://pubmed.ncbi.nlm.nih.gov/31104346

Zobrazit plný text záznamu

Use of Hepatitis C Virus Antibody-Positive Donor Livers in Hepatitis C Nonviremic Liver Transplant Recipients

Autor: Tayyab S. Diwan, Tiffany E. Kaiser, Madison C. Cuffy, Shimul A. Shah, Nadeem Anwar, Senu Apewokin, Khurram Bari, Keith Luckett, Kamran Safdar, Michael R. Schoech

Publikováno v: Journal of the American College of Surgeons. 228(4)

Background Given the shortage of available liver grafts, transplantation (LTx) of hepatitis C virus antibody-positive, nucleic acid test-negative (HCV Ab+/NAT-) livers into nonviremic HCV recipients can expand the donor pool. Having previously descri

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::73f0e6029a8952e80796630a473806a2
https://pubmed.ncbi.nlm.nih.gov/31561801

Zobrazit plný text záznamu

Histoplasmosis in Patients With Cell-Mediated Immunodeficiency: Human Immunodeficiency Virus Infection, Organ Transplantation, and Tumor Necrosis Factor-α Inhibition

Autor: Keith Luckett, J. Stephen Dummer, Geraldine G. Miller, Lora D. Thomas, Sydney Hester

Publikováno v: Open Forum Infectious Diseases

Background. Histoplasmosis causes severe disease in patients with defects of cell-mediated immunity. It is not known whether outcomes vary related to the type of immunodeficiency or class of antifungal treatment. Methods. We reviewed cases of active

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::36679f6227b78e3f54e933f72894a5ef
http://europepmc.org/articles/PMC4438880

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání